Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To determine the pharmacokinetic profile of generic lopinavir/ritonavir tablets To
investigate the possible influence of pregnancy and duration of pregnancy To determine the
antiviral activity and safety of generic lopinavir/ritonavir® Compare pharmacokinetics
parameters before and after pregnancy.
Phase:
Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration